Single-lung transplantation with ABO-compatible donors results in excellent outcomes

Sharven Taghavi, Senthil N. Jayarajan, Yuka Furuya, Eugene Komaroff, Akira Shiose, Eros Leotta, Kazuhiro Hisamoto, Namrata Patel, Francis Cordova, Gerard Criner, T. Sloane Guy, Yoshiya Toyoda

研究成果: ジャーナルへの寄稿記事

8 引用 (Scopus)

抄録

Background The goal of this study was to determine if carefully selected ABO-compatible donors in single-lung transplantation results in acceptable outcomes. Methods The United Network for Organ Sharing database was reviewed for adult single-lung transplant recipients from May 2005 to December 2011. Recipients of lungs from ABO-compatible donors were compared with those of ABO-identical donors. Mortality was examined with risk-adjusted multivariable Cox proportional hazards regression using significant univariate predictors. Results Of 3,572 single-lung transplants, 342 (9.6%) were from ABO-compatible donors. The two groups were evenly matched in recipient age (60.8 vs 60.2 years, p = 0.28), male gender (61.8% vs 58.2%, p = 0.10), lung allocation score (43.4 vs 42.6, p = 0.32), forced expiratory volume in 1 second (FEV1; 41.2% vs 40.8%, p = 0.32), and ischemic time (4.2 vs 4.0 hours, p = 0.09), and donor age (34.4 vs 32.9, p = 0.07) and male gender (61.5 vs 65.5, p = 0.14). ABO-compatible donors were less likely to be race mismatched (58.3% vs 50.9%, p = 0.01). Median survival was not different (1,284.0 vs 1,540 days, p = 0.39). On multivariate analysis, lungs from ABO-compatible donors were not associated with mortality (hazard ratio, 1.02; 95% confidence interval, 0.85-1.22; p = 0.86). Prolonged ischemic time, increasing recipient creatinine, increasing recipient age, race mismatch, class I plasma reactive antigen panel > 10%, and the use of mechanical ventilation or extracorporeal membrane oxygenation were associated with mortality. Peak post-transplant FEV1 (64.5% vs 64.0%, p = 0.69) and decrement in FEV1 over time were similar (p = 0.82). Conclusions This large multi-institutional analysis of ABO-compatible donors in single-lung transplantation demonstrates that careful selection of ABO-compatible donors results in excellent outcomes.

元の言語英語
ページ(範囲)822-828
ページ数7
ジャーナルJournal of Heart and Lung Transplantation
33
発行部数8
DOI
出版物ステータス出版済み - 1 1 2014
外部発表Yes

Fingerprint

Lung Transplantation
Tissue Donors
Lung
Mortality
Transplants
Extracorporeal Membrane Oxygenation
Forced Expiratory Volume
Artificial Respiration
Creatinine
Multivariate Analysis
Databases
Confidence Intervals
Antigens
Survival

All Science Journal Classification (ASJC) codes

  • Transplantation
  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery
  • Medicine(all)

これを引用

Single-lung transplantation with ABO-compatible donors results in excellent outcomes. / Taghavi, Sharven; Jayarajan, Senthil N.; Furuya, Yuka; Komaroff, Eugene; Shiose, Akira; Leotta, Eros; Hisamoto, Kazuhiro; Patel, Namrata; Cordova, Francis; Criner, Gerard; Guy, T. Sloane; Toyoda, Yoshiya.

:: Journal of Heart and Lung Transplantation, 巻 33, 番号 8, 01.01.2014, p. 822-828.

研究成果: ジャーナルへの寄稿記事

Taghavi, S, Jayarajan, SN, Furuya, Y, Komaroff, E, Shiose, A, Leotta, E, Hisamoto, K, Patel, N, Cordova, F, Criner, G, Guy, TS & Toyoda, Y 2014, 'Single-lung transplantation with ABO-compatible donors results in excellent outcomes', Journal of Heart and Lung Transplantation, 巻. 33, 番号 8, pp. 822-828. https://doi.org/10.1016/j.healun.2014.04.006
Taghavi, Sharven ; Jayarajan, Senthil N. ; Furuya, Yuka ; Komaroff, Eugene ; Shiose, Akira ; Leotta, Eros ; Hisamoto, Kazuhiro ; Patel, Namrata ; Cordova, Francis ; Criner, Gerard ; Guy, T. Sloane ; Toyoda, Yoshiya. / Single-lung transplantation with ABO-compatible donors results in excellent outcomes. :: Journal of Heart and Lung Transplantation. 2014 ; 巻 33, 番号 8. pp. 822-828.
@article{44eae9935c464714a15cd16b950a1770,
title = "Single-lung transplantation with ABO-compatible donors results in excellent outcomes",
abstract = "Background The goal of this study was to determine if carefully selected ABO-compatible donors in single-lung transplantation results in acceptable outcomes. Methods The United Network for Organ Sharing database was reviewed for adult single-lung transplant recipients from May 2005 to December 2011. Recipients of lungs from ABO-compatible donors were compared with those of ABO-identical donors. Mortality was examined with risk-adjusted multivariable Cox proportional hazards regression using significant univariate predictors. Results Of 3,572 single-lung transplants, 342 (9.6{\%}) were from ABO-compatible donors. The two groups were evenly matched in recipient age (60.8 vs 60.2 years, p = 0.28), male gender (61.8{\%} vs 58.2{\%}, p = 0.10), lung allocation score (43.4 vs 42.6, p = 0.32), forced expiratory volume in 1 second (FEV1; 41.2{\%} vs 40.8{\%}, p = 0.32), and ischemic time (4.2 vs 4.0 hours, p = 0.09), and donor age (34.4 vs 32.9, p = 0.07) and male gender (61.5 vs 65.5, p = 0.14). ABO-compatible donors were less likely to be race mismatched (58.3{\%} vs 50.9{\%}, p = 0.01). Median survival was not different (1,284.0 vs 1,540 days, p = 0.39). On multivariate analysis, lungs from ABO-compatible donors were not associated with mortality (hazard ratio, 1.02; 95{\%} confidence interval, 0.85-1.22; p = 0.86). Prolonged ischemic time, increasing recipient creatinine, increasing recipient age, race mismatch, class I plasma reactive antigen panel > 10{\%}, and the use of mechanical ventilation or extracorporeal membrane oxygenation were associated with mortality. Peak post-transplant FEV1 (64.5{\%} vs 64.0{\%}, p = 0.69) and decrement in FEV1 over time were similar (p = 0.82). Conclusions This large multi-institutional analysis of ABO-compatible donors in single-lung transplantation demonstrates that careful selection of ABO-compatible donors results in excellent outcomes.",
author = "Sharven Taghavi and Jayarajan, {Senthil N.} and Yuka Furuya and Eugene Komaroff and Akira Shiose and Eros Leotta and Kazuhiro Hisamoto and Namrata Patel and Francis Cordova and Gerard Criner and Guy, {T. Sloane} and Yoshiya Toyoda",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.healun.2014.04.006",
language = "English",
volume = "33",
pages = "822--828",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Single-lung transplantation with ABO-compatible donors results in excellent outcomes

AU - Taghavi, Sharven

AU - Jayarajan, Senthil N.

AU - Furuya, Yuka

AU - Komaroff, Eugene

AU - Shiose, Akira

AU - Leotta, Eros

AU - Hisamoto, Kazuhiro

AU - Patel, Namrata

AU - Cordova, Francis

AU - Criner, Gerard

AU - Guy, T. Sloane

AU - Toyoda, Yoshiya

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background The goal of this study was to determine if carefully selected ABO-compatible donors in single-lung transplantation results in acceptable outcomes. Methods The United Network for Organ Sharing database was reviewed for adult single-lung transplant recipients from May 2005 to December 2011. Recipients of lungs from ABO-compatible donors were compared with those of ABO-identical donors. Mortality was examined with risk-adjusted multivariable Cox proportional hazards regression using significant univariate predictors. Results Of 3,572 single-lung transplants, 342 (9.6%) were from ABO-compatible donors. The two groups were evenly matched in recipient age (60.8 vs 60.2 years, p = 0.28), male gender (61.8% vs 58.2%, p = 0.10), lung allocation score (43.4 vs 42.6, p = 0.32), forced expiratory volume in 1 second (FEV1; 41.2% vs 40.8%, p = 0.32), and ischemic time (4.2 vs 4.0 hours, p = 0.09), and donor age (34.4 vs 32.9, p = 0.07) and male gender (61.5 vs 65.5, p = 0.14). ABO-compatible donors were less likely to be race mismatched (58.3% vs 50.9%, p = 0.01). Median survival was not different (1,284.0 vs 1,540 days, p = 0.39). On multivariate analysis, lungs from ABO-compatible donors were not associated with mortality (hazard ratio, 1.02; 95% confidence interval, 0.85-1.22; p = 0.86). Prolonged ischemic time, increasing recipient creatinine, increasing recipient age, race mismatch, class I plasma reactive antigen panel > 10%, and the use of mechanical ventilation or extracorporeal membrane oxygenation were associated with mortality. Peak post-transplant FEV1 (64.5% vs 64.0%, p = 0.69) and decrement in FEV1 over time were similar (p = 0.82). Conclusions This large multi-institutional analysis of ABO-compatible donors in single-lung transplantation demonstrates that careful selection of ABO-compatible donors results in excellent outcomes.

AB - Background The goal of this study was to determine if carefully selected ABO-compatible donors in single-lung transplantation results in acceptable outcomes. Methods The United Network for Organ Sharing database was reviewed for adult single-lung transplant recipients from May 2005 to December 2011. Recipients of lungs from ABO-compatible donors were compared with those of ABO-identical donors. Mortality was examined with risk-adjusted multivariable Cox proportional hazards regression using significant univariate predictors. Results Of 3,572 single-lung transplants, 342 (9.6%) were from ABO-compatible donors. The two groups were evenly matched in recipient age (60.8 vs 60.2 years, p = 0.28), male gender (61.8% vs 58.2%, p = 0.10), lung allocation score (43.4 vs 42.6, p = 0.32), forced expiratory volume in 1 second (FEV1; 41.2% vs 40.8%, p = 0.32), and ischemic time (4.2 vs 4.0 hours, p = 0.09), and donor age (34.4 vs 32.9, p = 0.07) and male gender (61.5 vs 65.5, p = 0.14). ABO-compatible donors were less likely to be race mismatched (58.3% vs 50.9%, p = 0.01). Median survival was not different (1,284.0 vs 1,540 days, p = 0.39). On multivariate analysis, lungs from ABO-compatible donors were not associated with mortality (hazard ratio, 1.02; 95% confidence interval, 0.85-1.22; p = 0.86). Prolonged ischemic time, increasing recipient creatinine, increasing recipient age, race mismatch, class I plasma reactive antigen panel > 10%, and the use of mechanical ventilation or extracorporeal membrane oxygenation were associated with mortality. Peak post-transplant FEV1 (64.5% vs 64.0%, p = 0.69) and decrement in FEV1 over time were similar (p = 0.82). Conclusions This large multi-institutional analysis of ABO-compatible donors in single-lung transplantation demonstrates that careful selection of ABO-compatible donors results in excellent outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84905090628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905090628&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2014.04.006

DO - 10.1016/j.healun.2014.04.006

M3 - Article

C2 - 24880825

AN - SCOPUS:84905090628

VL - 33

SP - 822

EP - 828

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 8

ER -